Search research articles
Contact Us
Filters
Showing results (241-250 of 274) with videos related to
Page
of 28
Sort By:
Chemmedchem
|
December 17, 2024
Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition
Lhana Tisseur, Sandrine Cojean, Khadidiatou Gassama, et al.
Molecules (Basel, Switzerland)
|
August 7, 2021
Betulin, a Newly Characterized Compound in <i>Acacia auriculiformis</i> Bark, Is a Multi-Target Protein Kinase Inhibitor
Augustine A Ahmadu, Claire Delehouzé, Anas Haruna, et al.
European Journal of Medicinal Chemistry
|
November 5, 2020
In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition
Marc-Antoine Bazin, Sandrine Cojean, Fabrice Pagniez, et al.
Molecular Oncology
|
April 23, 2009
MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S
Jean Bénard, Gilda Raguénez, Audrey Kauffmann, et al.
Stroke
|
February 9, 2019
Home-Time as a Surrogate Marker for Functional Outcome After Aneurysmal Subarachnoid Hemorrhage
Martin Nikolaus Stienen, Nicolas Roydon Smoll, Christian Fung, et al.
The Journal of Infectious Diseases
|
August 20, 2020
Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19
Christophe Guervilly, Stephane Burtey, Florence Sabatier, et al.
RSC Medicinal Chemistry
|
June 23, 2025
Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-<i>a</i>]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy
Lhana Tisseur, Cédric Logé, Sandrine Cojean, et al.
Neurosurgery
|
May 16, 2018
Measuring the Impact of Delayed Cerebral Ischemia on Neuropsychological Outcome After Aneurysmal Subarachnoid Hemorrhage-Protocol of a Swiss Nationwide Observational Study (MoCA-DCI Study)
Martin N Stienen, Christian Fung, Philippe Bijlenga, et al.
Cancer Research
|
July 10, 2007
A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib
Thibault de La Motte Rouge, Lorenzo Galluzzi, Ken A Olaussen, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 27, 2025
New Insights into the Anticancer Effects and Toxicogenomic Safety of Two β-Lapachone Derivatives
José Rivaldo De Lima, Alexandre José Da Silva Góes, Elizabeth Fernanda De Oliveira Borba, et al.
Page
of 28
Search research articles
Search
Showing results (241-250 of 274) with videos related to
Sort By:
Page
of 28
Chemmedchem
|
December 17, 2024
Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition
Lhana Tisseur, Sandrine Cojean, Khadidiatou Gassama, et al.
Molecules (Basel, Switzerland)
|
August 7, 2021
Betulin, a Newly Characterized Compound in <i>Acacia auriculiformis</i> Bark, Is a Multi-Target Protein Kinase Inhibitor
Augustine A Ahmadu, Claire Delehouzé, Anas Haruna, et al.
European Journal of Medicinal Chemistry
|
November 5, 2020
In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition
Marc-Antoine Bazin, Sandrine Cojean, Fabrice Pagniez, et al.
Molecular Oncology
|
April 23, 2009
MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S
Jean Bénard, Gilda Raguénez, Audrey Kauffmann, et al.
Stroke
|
February 9, 2019
Home-Time as a Surrogate Marker for Functional Outcome After Aneurysmal Subarachnoid Hemorrhage
Martin Nikolaus Stienen, Nicolas Roydon Smoll, Christian Fung, et al.
The Journal of Infectious Diseases
|
August 20, 2020
Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19
Christophe Guervilly, Stephane Burtey, Florence Sabatier, et al.
RSC Medicinal Chemistry
|
June 23, 2025
Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-<i>a</i>]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy
Lhana Tisseur, Cédric Logé, Sandrine Cojean, et al.
Neurosurgery
|
May 16, 2018
Measuring the Impact of Delayed Cerebral Ischemia on Neuropsychological Outcome After Aneurysmal Subarachnoid Hemorrhage-Protocol of a Swiss Nationwide Observational Study (MoCA-DCI Study)
Martin N Stienen, Christian Fung, Philippe Bijlenga, et al.
Cancer Research
|
July 10, 2007
A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib
Thibault de La Motte Rouge, Lorenzo Galluzzi, Ken A Olaussen, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 27, 2025
New Insights into the Anticancer Effects and Toxicogenomic Safety of Two β-Lapachone Derivatives
José Rivaldo De Lima, Alexandre José Da Silva Góes, Elizabeth Fernanda De Oliveira Borba, et al.
Page
of 28